Lack of rapid aldosterone effects on forearm resistance vasculature in health

被引:33
作者
Gunaruwan, P
Schmitt, M
Taylor, J
Lee, L
Struthers, A
Frenneaux, M
机构
[1] Univ Wales Coll Cardiff, Dept Cardiol, Wales Heart Res Inst, Coll Med, Cardiff CF14 4XN, S Glam, Wales
[2] Univ Dundee, Ninewells Hosp & Med Sch, Dept Clin Pharmacol & Therapeut, Dundee DD1 9SY, Scotland
关键词
aldosterone; forearm vascular resistance;
D O I
10.3317/jraas.2002.013
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Objectives Systemic infusions of aldosterone cause an acute increase in systemic vascular resistance (SVR) in healthy subjects. It is not clear whether this is due to a direct effect on the vasculature or the result of increased sympathetic tone. We investigated the short-term effects of locally infused aldosterone on the forearm resistance bed. Methods In this dose response study, we assessed the effects of incremental doses (10, 50, 100 ng/minute) of intrabrachial aldosterone on forearm blood flow (FBF), using conventional strain gauge plethysmography. Arterial blood pressure was monitored continuously, using finger photoplethysmography. Forearm vascular resistance (FVR) was calculated. FBF and FVR were also measured in the non-infused arm. Changes in FBF and FVR in the infused arm were corrected for those occurring in the control arm. Results Plasma aldosterone levels in the venous effluent of the infused arm increased in a dose-dependent fashion, from 113.3+/-17.9 pg/ml at baseline to 297.8+/-51.8 pg/ml at 10 ng/minute (p=<0.01), 743.9+/-105.9 pg/ml at 50 ng/min (p=<0.001 vs. baseline) and 1230.6+/-73.7 pg/ml at 100 ng/min (p=<0.0005 vs. baseline). Plasma concentrations of aldosterone in the control arm did not change significantly vs. baseline. The corrected FBF (+4.1+/-10.3%) and corrected FVR (+4.3+/-11.3%) did not change significantly even at peak infusion rates. Conclusions Local intra-arterial infusion of aldosterone had no acute effect on forearm resistance vessels in healthy male volunteers.
引用
收藏
页码:123 / 125
页数:3
相关论文
共 25 条
[1]   Aldosterone [J].
Booth, RE ;
Johnson, JP ;
Stockand, JD .
ADVANCES IN PHYSIOLOGY EDUCATION, 2002, 26 (01) :8-20
[2]   REGULATION OF THE STRUCTURAL REMODELING OF THE MYOCARDIUM - FROM HYPERTROPHY TO HEART-FAILURE [J].
BRILLA, CG ;
MAISCH, B .
EUROPEAN HEART JOURNAL, 1994, 15 :45-52
[3]  
BRILLA CG, 1992, J LAB CLIN MED, V120, P893
[4]   Renin-angiotensin-aldosterone system and myocardial fibrosis [J].
Brilla, CG .
CARDIOVASCULAR RESEARCH, 2000, 47 (01) :1-3
[5]   MYOCARDIAL COLLAGEN MATRIX REMODELING IN ARTERIAL-HYPERTENSION [J].
BRILLA, CG ;
MAISCH, B ;
WEBER, KT .
EUROPEAN HEART JOURNAL, 1992, 13 :24-32
[6]   Aldosterone and myocardial fibrosis in heart failure [J].
Brilla, CG .
HERZ, 2000, 25 (03) :299-306
[7]   Aldosterone, not estradiol, is the physiological agonist for rapid increases in cAMP in vascular smooth muscle cells [J].
Christ, M ;
Günther, A ;
Heck, M ;
Schmidt, BMW ;
Falkenstein, E ;
Wehling, M .
CIRCULATION, 1999, 99 (11) :1485-1491
[8]   RAPID EFFECTS OF ALDOSTERONE ON SODIUM-TRANSPORT IN VASCULAR SMOOTH-MUSCLE CELLS [J].
CHRIST, M ;
DOUWES, K ;
EISEN, C ;
BECHTNER, G ;
THEISEN, K ;
WEHLING, M .
HYPERTENSION, 1995, 25 (01) :117-123
[9]   Inverse relationship between aldosterone and large artery compliance in chronically treated heart failure patients [J].
Duprez, DA ;
De Buyzere, NL ;
Rietzschel, ER ;
Taes, Y ;
Clement, DL ;
Morgan, D ;
Cohn, JN .
EUROPEAN HEART JOURNAL, 1998, 19 (09) :1371-1376
[10]   Aldosterone activates Na+/H+ exchange in vascular smooth muscle cells by nongenomic and genomic mechanisms [J].
Ebata, S ;
Muto, S ;
Okada, K ;
Nemoto, J ;
Amemiya, M ;
Saito, T ;
Asano, Y .
KIDNEY INTERNATIONAL, 1999, 56 (04) :1400-1412